Centralised versus local measurement of glycated haemoglobin in clinical trial settings: a comment on Arch et al., Trials. 2016

Arch and colleagues in their 24 October 2016 paper in Trials focus on the issue of centralised versus local measurement of glycated haemoglobin (HbA1c) in clinical trial settings. Resolution of the debate is important: while local HbA1c measurement is less costly, and would thereby ease the stretche...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Sudip, Pradhan, Richeek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433151/
https://www.ncbi.nlm.nih.gov/pubmed/28506285
http://dx.doi.org/10.1186/s13063-017-1944-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433151/
https://www.ncbi.nlm.nih.gov/pubmed/28506285
http://dx.doi.org/10.1186/s13063-017-1944-1

Ejemplares similares